A35V (p.Ala35Val) variant of NLGN3 (Neuroligin-3)
A35V (p.Ala35Val) in NLGN3 (Neuroligin-3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data and structural context.
A35V (p.Ala35Val) variant details
- p.Ala35Val
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.227
- REVEL 0.10
- CADD 15.10
- PolyPhen-2 0.00
- SIFT 0.73
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available